Apolipoprotein E in cerebrospinal fluid: Relation to phenotype and plasma apolipoprotein E concentrations

Clinical Chemistry

Volumn 45, Issue 4, 1999, Pages 497-504

  Yamauchi, Kazuyoshi ^a   Tozuka, Minoru ^a   Nakabayashi, Tetsuo ^a   Sugano, Mitsutoshi ^a   Hidaka, Hiroya ^a   Kondo, Yoshiyuki ^b   Katsuyama, Tsutomu ^c  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; PHOSPHOLIPID;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MALE; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; QUANTITATIVE ASSAY; TURBIDIMETRY;

EID: 0032917743     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.4.497     Document Type: Article

References (36)

1. 1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology [Review]. Science 1988;240:622-30.
2. 2. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 1989;341:162-4.
3. 3. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 1985;82:203-7.
4. 4. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Investig 1985;76:1501-13.
5. 5. Zannis VI, Breslow JL. Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia. J Biol Chem 1980;255: 1759-62.
6. 6. Zannis VI, Breslow JL. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry 1981; 20:1033-41.
7. 7. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis [Review]. Arteriosclerosis 1988;8:1-21.
8. 8. Roheim PS, Carey M, Forte T, Vega GL. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A 1979;76:4646-9.
9. 9. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. J Biol Chem 1987;262:14352-60.
10. 10. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917:148-61.
11. 11. Swanson LW, Simmons DM, Hofmann SL, Goldstein JL, Brown MS. Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization. Proc Natl Acad Sci U S A 1988;85:9821-5.
12. 12. Fabrizi C, Businaro R, Persichini T, Fumagalli L, Lauro GM. The expression of the LDL receptor-related protein (LRP) correlates with the differentiation of human neuroblastoma. Brain Res 1997;776:154-61.
13. 13. Rifai N, Christenson RH, Gelman BB, Silverman LM. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. Clin Chem 1987;33:1155-7.
14. 14. Gelman BB, Rifai N, Christenson RH, Silverman LM. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Ann Clin Lab Sci 1988;18:46-52.
15. 15. Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D. Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta 1991;196:167-76.
16. 16. Blennow K, Hasse C, Fredman P. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport 1994;5: 2534-6.
17. 17. Lehtimäki T, Pirttilä T, Mehta PD, Wisniewski HM, Frey H, Nikkari T. Apolipoprotein E (apoE) polymorphism and its influence on apoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum Genet 1995;95:39-42.
18. 18. Skene JH, Shooter EM. Denervated sheath cells secrete a new protein after nerve injury. Proc Natl Acad Sci U S A 1983;80: 4169-73.
19. 19. Ignatius MJ, Gebicke-Härter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A 1986;83:1125-9.
20. 20. Ignatius MJ, Gebicke-Härter PJ, Pitas RE, Shooter EM. Apolipoprotein E in nerve injury and repair. Prog Brain Res 1987;71:177-84.
21. 21. Bury J, Vercaemst R, Rosseneu M, Belpaire F. Apolipoprotein E quantified by enzyme-linked immunosorbent assay. Clin Chem 1986;32:265-70.
22. 22. Tozuka M, Hidaka H, Miyachi M, Furihata K, Katsuyama T, Kanai M. Identification and characterization of apolipoprotein (A11-E2-A11) complex in human plasma lipoprotein. Biochim Biophys Acta 1992;1165:61-7.
23. 23. Tajima S, Yamamura T, Yamamoto A. Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia. J Biochem (Tokyo) 1988;104:48-52.
24. 24. Lipids Research Clinics Program Epidemiology Committee. Plasma lipid distribution in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1979;60:427-39.
25. 25. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90: 1977-81.
26. 26. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease [Letter]. Lancet 1993;342:737.
27. 27. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families [see comments]. Science 1993;261:921-3.
28. 28. Van Duijin CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease [see comments]. Nat Genet 1994;7:74-8.
29. 29. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541: 163-6.
30. 30. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:8098-102.
31. 31. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994;269:23403-6.
32. 32. Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, et al. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem 1997;69:1995-2004.
33. 33. Castano EM, Prelli F, Pras M, Frangione B. Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease. J Biol Chem 1995;270:17610-5.
34. 34. de Silva HV, Harmony JA, Stuart WD, Gil CM, Robbins J. Apolipoprotein J: structure and tissue distribution. Biochemistry 1990; 29:5380-9.
35. 35. LaDu MJ, Gilligan SM, Lukens JR, Cabana VG, Reardon CA, Van Eldik LJ, et al. Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 1998;70:2070-81.
36. 36. Guyton JR, Miller SE, Martin ME, Khan WA, Roses AD, Strittmatter WJ. Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/mL in human cerebrospinal fluid. J Neurochem 1998;70:1235-40.